HR 5699 United States House · 118th Congress

Charles Rochester Blood Clot Prevention and Treatment Act

This bill directs the CDC to launch public education campaigns about blood clot risks, symptoms, and prevention, with special focus on high-risk groups including Black Americans, cancer patients, seniors, and hospitalized individuals. It creates a new 18-month advisory committee to study DVT/PE data collection, develop prevention guidelines, and recommend improved care standards for at-risk patients. The bill also mandates a federal study on electronic health record systems for better DVT/PE surveillance and authorizes $20 million annually for these efforts through fiscal year 2029. These provisions aim to reduce preventable deaths and improve early diagnosis, directly affecting millions at risk of blood clots nationwide.
Bill status in committee 1 of 4 stages cleared
Introduction
Sep 2023
Committee Review
Floor Vote
President
Introduced Sep 26, 2023 Last action Sep 29, 2023